Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases

Overview of attention for article published in Malaria Journal, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 22 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 23,018 followers.

RT @siqueira__andre: We published @MalariaJournal a report of 3 cases with low cyp2d6 activity treated with 2x usual primaquine dose (7mg/k…

24 Apr 2022

Reply Repost Favourite

RT @siqueira__andre: We published @MalariaJournal a report of 3 cases with low cyp2d6 activity treated with 2x usual primaquine dose (7mg/k…

23 Apr 2022

Reply Repost Favourite

RT @siqueira__andre: We published @MalariaJournal a report of 3 cases with low cyp2d6 activity treated with 2x usual primaquine dose (7mg/k…

20 Apr 2022

Reply Repost Favourite

We published @MalariaJournal a report of 3 cases with low cyp2d6 activity treated with 2x usual primaquine dose (7mg/kg) to prevent vivax malaria relapses. Curavivax @marcuslacerda77 and ABRACAMAL funded by @gatesfoundation will provide more on this. https

15 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.